Add 2 More Reports For 20% off

Report Overview

Central retinal vein occlusion (CRVO), a common retinal vascular disorder, has two types, namely, ischemic and non-ischemic, with some patients presenting intermediate features. Over 90% of patients with ischemic CRVO experience final visual acuity of 20/200 or worse. Anterior segment neovascularisation occurs in more than 60% of cases, with related complications typically arising within weeks to two years after the onset of the condition.

2024

Base Year

2018-2024

Historical Year

2025-2034

Forecast Year

Central Retinal Venous Occlusion Epidemiology Forecast Report Coverage

Expert Market Research's “Central Retinal Venous Occlusion Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of central retinal venous occlusion. It projects the future incidence and prevalence rates of central retinal venous occlusion across various populations. The study covers age, gender, and type as major determinants of the central retinal venous occlusion-affected population. The report highlights patterns in the prevalence of central retinal venous occlusion over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of central retinal venous occlusion in the 8 major markets.

Regions Covered

  • The United States
  • Germany
  • France
  • Italy
  • Spain
  • The United Kingdom
  • Japan
  • India

Central Retinal Venous Occlusion Disease Overview

Central retinal venous occlusion (CRVO) occurs when the main vein draining blood from the retina becomes blocked, usually due to a blood clot. This blockage leads to impaired blood flow, causing retinal swelling, hemorrhages, and vision problems. Risk factors include high blood pressure, diabetes, glaucoma, and clotting disorders. Symptoms often include sudden, painless vision loss or blurring in one eye. CRVO is classified as non-ischemic or ischemic, with the latter posing a higher risk of severe vision loss. Treatment includes managing underlying conditions, anti-VEGF injections, or laser therapy to reduce complications.

Central Retinal Venous Occlusion: Treatment Overview

Central retinal vein occlusion (CRVO) treatment aims to manage complications, improve vision, and prevent progression. Management includes anti-vascular endothelial growth factor (VEGF) injections, corticosteroids, and addressing risk factors like hypertension and diabetes to reduce recurrence or bilateral involvement. Corticosteroid implants may also be employed in specific cases. Addressing underlying risk factors, such as hypertension, diabetes, and glaucoma, is critical to reducing recurrence and preventing bilateral involvement. For non-ischemic CRVO, complete recovery occurs in only 10% of cases, while 50% experience 20/200 or worse vision, and 34% convert to ischemic CRVO within three years.

Epidemiology

The central retinal venous occlusion epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for central retinal venous occlusion by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for central retinal venous occlusion and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

  • CRVO is slightly more common in males and occurs in over 90% of individuals aged above 50 years, though cases are reported in all age groups. There is no racial preference.
  • Non-ischemic CRVO resolves completely in approximately 10% of cases, while 50% of patients experience vision of 20/200 or worse. Around one-third of cases progress to ischemic CRVO, often within 6-12 months.
  • Retinal vein occlusion may develop in the fellow eye in 7% of cases within two years. The 4-year risk is 2.5% in the same eye and 11.9% in the fellow eye.
  • Hypertension, present in 73% of patients over 50 and 25% of younger patients, significantly increases the risk of recurrence in either eye.

Country-wise Central Retinal Venous Occlusion Epidemiology

The central retinal venous occlusion epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of central retinal vein occlusion (CRVO) varies globally, being the second most common retinal vascular disorder. Non-ischemic CRVO is more prevalent than the ischemic type. In the United States, Europe, Asia, and Australia, pooled data indicate CRVO affects 0.8 per 1,000 individuals. The Beaver Dam Eye Study reported a 15-year cumulative incidence of 0.5%. In Israel, the 4-year incidence is 2.14 per 1,000 individuals over 40 years, increasing to 5.36 per 1,000 above 64 years. In Australia, prevalence ranges from 0.7% at ages 49-60 to 4.6% in those over 80 years.

Country Specific Stats:

Country

Prevalence (Unit)

United States

0.8 in 1000

United Kingdom

XX

Germany

XX

Italy

XX

France

XX

Spain

XX

Japan

XX

India

XX

Scope of the Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of central retinal venous occlusion based on several factors.
  • Central Retinal Venous Occlusion Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The report helps to identify the patient population and the unmet needs of central retinal venous occlusion are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

  • What are the key findings of central retinal venous occlusion epidemiology in the 8 major markets?
  • What will be the total number of patients with central retinal venous occlusion across the 8 major markets during the forecast period?
  • What was the country-wise prevalence of central retinal venous occlusion in the 8 major markets in the historical period?
  • Which country will have the highest number of central retinal venous occlusion patients during the forecast period of 2025-2034?
  • Which key factors would influence the shift in the patient population of central retinal venous occlusion during the forecast period of 2025-2034?
  • What are the currently available treatments for central retinal venous occlusion?
  • What are the disease risks, signs, symptoms, and unmet needs of central retinal venous occlusion?

Related Reports

Global Glaucoma Therapeutics Market

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Report Features

Details

Base Year

2024

Historical Period

2018-2024

Forecast Period

2025-2034

Epidemiology Statistics Provided

  • Diagnosed Prevalent Cases
  • Type-Specific Cases
  • Gender-Specific Cases
  • Age-Specific Cases

Segmentation Provided

  • Epidemiology by Age Group
  • Epidemiology by Gender
  • Epidemiology by Type of Disease
  • Epidemiology by Region

Geographies Covered

  • United States
  • Germany
  • Italy
  • France
  • Spain
  • United Kingdom
  • Japan
  • India

Datasheet

10 % Off

USD

1,999

1,799

Single User License

10 % Off

USD

2,999

2,699

Five User License

15 % Off

USD

4,399

3,739

Corporate License

15 % Off

USD

5,799

4,929

  • Report Delivery
  • Purchase Advantages
  • Access Duration
  • Analyst Support
  • Discount on Future Updates
  • Customisation Options
  • Customisation Requests
  • Excel Data Sheet
  • Online Access
  • PDF Format
  • PPT/Word Format
  • 1 Print Allowed
  • Bulk Purchase Discounts
  • Full Report Access
  • Multi-Device Access
  • Unlimited Access
  • One-Time Purchase
  • Annual Subscription
  • 3 Years Subscription
  • Email Support
  • Phone Support
  • Up to 15 Analyst Hours
  • Up to 30 Analyst Hours
  • 5% Discount
  • 10% Discount
  • 15% Discount
  • 20% Discount
  • Basic (Up to 10%)
  • Advanced (Up to 50%)
  • Dedicated Analyst Access
  • Consultations Hours
  • Custom Data Queries
  • Custom Report Layouts
  • Tailored Custom Summaries
  • Dashboard
  • Purchase Advantages
  • Report Delivery
  • Access Duration
  • Analyst Support
  • Discount on Future Updates
  • Customisation Options
  • Customisation Requests
  • 1 Print Allowed
  • Full Report Access
  • Bulk Purchase Discounts
  • Multi-Device Access
  • PDF Format
  • Online Access
  • Excel Data Sheet
  • PPT/Word Format
  • Unlimited Access
  • One-Time Purchase
  • Annual Subscription
  • 3 Years Subscription
  • Email Support
  • Phone Support
  • Up to 15 Analyst Hours
  • Up to 30 Analyst Hours
  • 10% Discount
  • 5% Discount
  • 15% Discount
  • 20% Discount
  • Basic (Up to 10%)
  • Advanced (Up to 50%)
  • Dedicated Analyst Access
  • Consultations Hours
  • Custom Data Queries
  • Custom Report Layouts
  • Tailored Custom Summaries
  • Dashboard
  • Purchase Advantages
  • Analyst Support
  • Report Delivery
  • Access Duration
  • Customisation Options
  • Discount on Future Updates
  • Customisation Requests
  • 5 Prints Allowed
  • Full Report Access
  • Bulk Purchase Discounts
  • Limited Device Access
  • Email Support
  • Phone Support
  • Up to 15 Analyst Hours
  • Up to 30 Analyst Hours
  • PDF Format
  • Online Access
  • Excel Data Sheet
  • PPT/Word Format
  • Unlimited Access
  • One-Time Purchase
  • Annual Subscription
  • 3 Years Subscription
  • Basic (Up to 10%)
  • Advanced (Up to 50%)
  • Dedicated Analyst Access
  • Consultations Hours
  • 15% Discount
  • 5% Discount
  • 10% Discount
  • 20% Discount
  • Custom Data Queries
  • Custom Report Layouts
  • Tailored Custom Summaries
  • Dashboard
  • Report Delivery
  • Purchase Advantages
  • Customisation Options
  • Analyst Support
  • Customisation Requests
  • Access Duration
  • Discount on Future Updates
  • PDF Format
  • Excel Data Sheet
  • PPT/Word Format
  • Online Access
  • 1 Print Allowed
  • Full Report Access
  • Bulk Purchase Discounts
  • Multi-Device Access
  • Basic (Up to 10%)
  • Advanced (Up to 50%)
  • Dedicated Analyst Access
  • Consultations Hours
  • Email Support
  • Phone Support
  • Up to 15 Analyst Hours
  • Up to 30 Analyst Hours
  • Custom Data Queries
  • Custom Report Layouts
  • Tailored Custom Summaries
  • Dashboard
  • Unlimited Access
  • One-Time Purchase
  • Annual Subscription
  • 3 Years Subscription
  • 20% Discount
  • 5% Discount
  • 10% Discount
  • 15% Discount

Datasheet

One User

USD 1,999

USD 1,799

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 2,999

USD 2,699

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 4,399

USD 3,739

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 5,799

USD 4,929

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124